Results 71 to 80 of about 199 (118)
World of 《Sanguozhi(三國志)》 and 《Sanguoyanyi(三國演義)》 in Sight Development of East Asia Legitimism
, 2016 Yeong-Rok Cho, null null
core +1 more source
Disputing Space and Citizenship: Popular Legitimism in 1848
, 2020 Bernard Rulof
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2021
This chapter studies why large social systems generate inequality. Half of it is bona fide returns to merit, while half of it is leverage of personal position into advantages for friends, families, and oneself. The organizations run by the elite take things from people and control their lives.
openaire +2 more sources
This chapter studies why large social systems generate inequality. Half of it is bona fide returns to merit, while half of it is leverage of personal position into advantages for friends, families, and oneself. The organizations run by the elite take things from people and control their lives.
openaire +2 more sources
“How Have We Let the Flag of Order (…) Slip Out of Our Hands?” Legitimism on the Defence, 1852–1883
, 2020 Bernard Rulof
exaly +2 more sources
Illness and the legitimation of failure
Nursing Research, 1972In achievement oriented societies one may use illness to justify failure to fulfill socially prescribed role obligations. This hypothesis is tested on two samples of welfare mothers and one sample of working class black women. Many welfare mothers accept the dominant cultural view that being on welfare is a result of personal failure. When women accept
S, Cole, R, Lejeune
openaire +2 more sources
European Public Law, 2003
The imposition of a 'fourth hurdle' of cost-effectiveness is becoming a common feature of the regulation of pharmaceuticals in several European countries. The National Institute for Clinical Excellence (NICE), which operates in England and Wales, is one of the most visible examples of this phenomenon and represents an influential model for reform ...
openaire +1 more source
The imposition of a 'fourth hurdle' of cost-effectiveness is becoming a common feature of the regulation of pharmaceuticals in several European countries. The National Institute for Clinical Excellence (NICE), which operates in England and Wales, is one of the most visible examples of this phenomenon and represents an influential model for reform ...
openaire +1 more source